KINTARO Cells

KINTARO Cells is an allogeneic bone marrow-derived mesenchymal stem cell therapy developed by Kintaro Cells Power for regenerative medicine applications including bone, muscle, blood vessel, organ, and skin regeneration. The product consists of CD34-negative mesenchymal stem cells obtained from young healthy donors and expanded using the company's proprietary cell-culture methods. Its proposed mechanism is the regenerative and reparative activity of mesenchymal stem cells through homing to injured tissue, paracrine trophic signaling, immunomodulatory effects, and multilineage differentiation potential rather than a single defined molecular target. Publicly available company materials describe broad regenerative use concepts and administration by intravenous, local, or exterior application, but do not disclose a formal clinical development phase or indication-specific pivotal program.

Brand names

KINTARO Cells

Other names

Kintaro CellsKINTARO Cells Power-cell therapy-allogeneic mesenchymal stem cells